The REVERSE-LC clinical trial of the immune-modulating biologic agent barcitinib expands to more sites across the country.
General Medicine
1
Posts
1
Posters
0
Views
-
The REVERSE-LC clinical trial of the immune-modulating biologic agent barcitinib expands to more sites across the country.
It's one of the only large-scale drug trials in long covid in the US. Check out the list of study sites at the link.
-
T #medicine shared this topic
